Fig. 1From: Synaptic biomarkers in the cerebrospinal fluid associate differentially with classical neuronal biomarkers in patients with Alzheimer’s disease and frontotemporal dementiaSchematic representation of the pre- and post-synaptic terminals of neurons. Aβ, amyloid beta; PTau, phosphorylated Tau (at threonine 181); NfL, neurofilament light chain; VAMP2, vesicle-associated membrane protein-2; SNAP25, synaptosomal associated protein-25; SNARE, SNAP Receptor Complex; NPTX2, neuronal pentraxin-2; GluR4, glutamate receptor-4; AMPAR, α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor; NMDAR, N-methyl-D-aspartate receptorBack to article page